<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Cardiac involvement means a poor prognosis in systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> (SSc) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0264886" disease_type="Disease or Syndrome" abbrv="">Conduction defects</z:e> and <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> are frequent in patients with SSc, and may result in <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We tested whether electrophysiologic studies and implantation of cardioverter defibrillators are recommended when <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> are present </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: A cardioverter defibrillator was implanted in 10 patients with SSc who had heart involvement </plain></SENT>
<SENT sid="4" pm="."><plain>RESULT: After 36 months, analysis of the device showed several <z:hpo ids='HP_0005141'>episodes of ventricular tachycardia</z:hpo> in 3 patients, which were promptly reverted by electrical shock delivery </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: In patients with SSc who are affected by <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo>, the implantation of a cardioverter defibrillator may prevent <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
</text></document>